Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2022-06-07 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically authorized and issued shares, for Yunkang Group Limited listed on the Hong Kong Stock Exchange. It includes data on share capital, issued shares, and confirms no movements in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance status for the month ended 31 May 2022. It is not a full financial report, earnings release, or management discussion, but a formal regulatory filing about share capital movements. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-06-07 English
Monthly Return of Equity Issuer on Movements in Securities (for the month ended 31 May 2022)
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 May 2022. It details movements in issued shares, share options, convertibles, and other share capital related information. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and securities movements for the month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing reporting share capital movements and related confirmations, consistent with a regulatory compliance filing rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2022-06-02 English
REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the revision of annual caps for continuing connected transactions between the company and a connected party, Da An Gene Group. It discusses regulatory compliance under the Hong Kong Listing Rules, the need for shareholder approval at the AGM, and details about the transaction amounts and pricing policies. The document is an announcement of a corporate action related to connected transactions and does not contain financial statements or detailed financial performance data. It is not a full annual report, interim report, or earnings release. It is also not a proxy solicitation or voting results announcement, but it references an upcoming AGM where shareholders will vote on the matter. The document is a regulatory announcement about connected transactions and compliance with listing rules, fitting best under Regulatory Filings (RNS).
2022-05-30 English
Final dividend declared for the year ended 31 March 2022
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides detailed information about a final dividend declared for the financial year ended 31 March 2022 by Lenovo Group Limited. It includes dividend amount, payment dates, record dates, and other related shareholder information. The document length is 3347 characters, which is relatively short and focused solely on dividend details. There is no financial performance data, management discussion, or other report content. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts and payment details to shareholders.
2022-05-26 English
FY2021/22 ANNUAL RESULTS ANNOUNCEMENT
Annual Report Classification · 95% confidence The document is titled 'FY2021/22 ANNUAL RESULTS ANNOUNCEMENT' and contains detailed audited financial results for the year ended March 31, 2022, including revenue, profit, segment performance, and business outlook. It includes comprehensive financial data and analysis, such as revenue breakdowns, profit margins, and business group performance. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Annual Report or a full-year financial report. The presence of detailed financial statements and business review confirms it is not just an earnings release or a regulatory filing. Therefore, the document should be classified as an Annual Report (10-K equivalent). FY 2022
2022-05-26 English
List of Directors and Their Roles and Functions
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors of Yunkang Group Limited, including their roles and committee memberships. It provides detailed information about the board structure and functions but does not include financial data, audit results, or other report content. The document is focused on governance and board composition. It is not an announcement of a report publication, nor is it a certification or a brief shareholder vote result. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management.
2022-05-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.